Synactix Pharmaceutical Inc.

Synactix Pharmaceutical Inc.
Anureet (sandy) Pabla
Student Innovation Fellow, 2014 – 2015
Tech Launch Arizona
Introduction
u 
u 
B.S. Molecular and Cellular Biology
u 
Minor in Business Administration
u 
Class of 2015 (Graduating in two weeks!)
What sparked my interest in commercialization
u 
Summer job as a Pharmacy Technician
u 
How did a drug end up on the shelf?
u 
Theranos – the lab test, reinvented
Synactix Pharmaceuticals Inc.
u 
Founded June 2014
u 
University of Arizona, department of pharmacology and
toxicology
u 
Drug Discovery, focus on the Medically underserved
u 
Dr. Hong-yu Li and Dr. Brendan Frett
u 
RET inhibitor which aids in the fight against cancer
u 
Medullary Thyroid Cancer
u 
4% out of all thyroid cancers (600,000)
Technology and Research
u 
Small Molecule Benefits
u 
Targets both RET and VEGFR-2
u  Active
on both sites
u 
Long shelf life
u 
Very specific – fragment drug discovery
u 
Water soluble
Comparable Drugs
u 
Same target, RET, VEGFR-2, MTC
u 
Clinical Trials for other cancers
u 
Toxic/ FDA approval Risks
Next Steps
u 
Start marketing the company more
u 
Develop the face of Synactix
u 
Keep options open
u 
Create goals and missions to help narrow in on what to do
The Fellows Experience
u 
Great real world experience in how processes like
commercialization work
u 
Exposure to the fluidity of a startup
u 
Great introduction to the pharmaceutical industry
u 
Influential to my future career and plans after graduation
u 
Met and worked with wonderful people and other Innovation
Fellows!